Multiple Sclerosis: Longitudinal Measurement of Interleukin-1 Receptor Antagonist.

Journal of Neurology, Neurosurgery and Psychiatry - United Kingdom
doi 10.1136/jnnp.62.2.200-b
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Interleukin-1, Interleukin-1 Receptor, and Interleukin-1 Receptor Antagonist

Proceedings of the Nutrition Society
MedicineNutritionDietetics
1994English

Deficiency of Interleukin-1 Receptor Antagonist Responsive to Anakinra

Pediatric Dermatology
DermatologyChild HealthPediatricsPerinatology
2012English

Structure Studies of Recombinant Interleukin-1 Receptor Antagonist Protein

Acta Crystallographica Section A Foundations of Crystallography
1993English

Arthritis Gene Therapy Using the Interleukin-1 Receptor Antagonist

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2018English

Interleukin 1 Receptor Antagonist Blocks Somnogenic and Pyrogenic Responses to an Interleukin 1 Fragment.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1992English

Expression of Interleukin-1 and Interleukin-1 Receptor Antagonist by Human Rheumatoid Synovial Tissue Macrophages

Clinical Immunology and Immunopathology
1992English

Interleukin-1 and Interleukin-1 Receptor Antagonist Gene Polymorphisms and Gastric Cancer: A Meta-Analysis

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2006English

Anti-Inflammatory Properties of a Novel Peptide Interleukin 1 Receptor Antagonist

Journal of Neuroinflammation
Molecular NeuroscienceNeurologyImmunologyCellularNeuroscience
2014English

Inflammation and Cardiovascular Disease: Role of the Interleukin-1 Receptor Antagonist

Circulation
Cardiovascular MedicinePhysiologyCardiology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy